Knowing that Card9-signaling stimulates the production of IL-1β in the damaged bowel and controls the subsequent generation of IL-22 by group3 innate lymphoid cells [153], the ability of lactobacilli to attenuate colitis indicates that the gut microbiota and their metabolites are involved in bowel inflammations. Here, IL22 is linked to colitis.